Hong Kong, China

Wai-Har Lam

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: The Hong Kong Polytechnic University, University of South Florida, Wayne State University. Active years: 2009-2015.

USPTO Granted Patents = 4 

% Patents Active = 100.0


Average Co-Inventor Count = 7.4

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2009-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Wai-Har Lam

Introduction

Wai-Har Lam is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of science, particularly in the area of cancer research. With a total of 4 patents to his name, Lam's work focuses on innovative methods for inhibiting tumor cell growth.

Latest Patents

Among his latest patents, Lam has developed a method involving (−)-Epigallocatechin gallate derivatives for inhibiting proteasome. This method includes administering an effective amount of a compound designed to reduce tumor cell growth. His research in this area showcases his commitment to advancing medical science and improving treatment options for cancer patients.

Career Highlights

Wai-Har Lam has had a distinguished career, working at prestigious institutions such as The Hong Kong Polytechnic University and Wayne State University. His roles at these universities have allowed him to engage in groundbreaking research and contribute to the academic community.

Collaborations

Lam has collaborated with esteemed colleagues, including Tak-Hang Chan and Larry Ming-Cheung Chow. These partnerships have further enriched his research and expanded the impact of his innovations.

Conclusion

Wai-Har Lam's contributions to the field of cancer research through his patents and collaborations highlight his role as a significant inventor. His work continues to inspire advancements in medical science and offers hope for improved cancer treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…